These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2026592)

  • 1. Peptidic mechanism-based inactivators for carboxypeptidase A.
    Ghosh SS; Wu YQ; Mobashery S
    J Biol Chem; 1991 May; 266(14):8759-64. PubMed ID: 2026592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A.
    Ghosh SS; Dakoji S; Tanaka Y; Cho YJ; Mobashery S
    Bioorg Med Chem; 1996 Sep; 4(9):1487-92. PubMed ID: 8894106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.
    Lee KJ; Kim DH
    Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of an effective mechanism-based inactivator for a zinc protease.
    Mobashery S; Ghosh SS; Tamura SY; Kaiser ET
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):578-82. PubMed ID: 2300547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A.
    Cho JH; Kim DH; Chung SJ; Ha NC; Oh BH; Yong Choi K
    Bioorg Med Chem; 2002 Jun; 10(6):2015-22. PubMed ID: 11937361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism-based inactivation study of neutral endopeptidase 24.11.
    Levy OE; Taibi P; Mobashery S; Ghosh SS
    J Med Chem; 1993 Aug; 36(16):2408-11. PubMed ID: 8360886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first mechanism-based inactivators for angiotensin-converting enzyme.
    Ghosh SS; Said-Nejad O; Roestamadji J; Mobashery S
    J Med Chem; 1992 Oct; 35(22):4175-9. PubMed ID: 1331459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insight into the inactivation of carboxypeptidase A by alpha-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity.
    Chung SJ; Chung S; Lee HS; Kim EJ; Oh KS; Choi HS; Kim KS; Kim YJ; Hahn JH; Kim DH
    J Org Chem; 2001 Sep; 66(19):6462-71. PubMed ID: 11559199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine.
    Park JD; Lee KJ; Kim DH
    Bioorg Med Chem; 2001 Feb; 9(2):237-43. PubMed ID: 11249116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A.
    Chung SJ; Kim DH
    Bioorg Med Chem; 2001 Jan; 9(1):185-9. PubMed ID: 11197339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy for designing irreversible inhibitors of metalloproteases: acetals as latent electrophiles that interact with catalytic nucleophile at the active site.
    Han MS; Ryu CH; Chung SJ; Kim DH
    Org Lett; 2000 Oct; 2(20):3149-52. PubMed ID: 11009368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible inhibition of zinc-containing protease by oxazolidinone derivatives. Novel inactivation chemistry.
    Kim DH; Chung SJ; Kim EJ; Tian GR
    Bioorg Med Chem Lett; 1998 Apr; 8(7):859-64. PubMed ID: 9871555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
    Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
    J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and kinetic evaluation of racemic and optically active 2-benzyl-2-methyl-3,4-epoxybutanoic acids as irreversible inactivators for carboxypeptidase A.
    Lee M; Kim DH
    Bioorg Med Chem; 2002 Apr; 10(4):913-22. PubMed ID: 11836098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippuryl-alpha-methylphenylalanine and hippuryl-alpha-methylphenyllactic acid as substrates for carboxypeptidase A. Syntheses, kinetic evaluation and mechanistic implication.
    Lee M; Kim DH
    Bioorg Med Chem; 2000 Apr; 8(4):815-23. PubMed ID: 10819170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
    Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
    J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a mechanism for reactive inhibition of carboxypeptidase A with QM/MM methods.
    Phoon L; Burton NA
    J Mol Graph Model; 2005 Oct; 24(2):94-101. PubMed ID: 16144767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Tyr248 probed by mutant bovine carboxypeptidase A: insight into the catalytic mechanism of carboxypeptidase A.
    Cho JH; Kim DH; Lee KJ; Kim DH; Choi KY
    Biochemistry; 2001 Aug; 40(34):10197-203. PubMed ID: 11513597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies of modifier effects on the carboxypeptidase A catalyzed hydrolyses of peptides.
    Sebastian JF; Hinks RS; Reuland RV
    Biochem Cell Biol; 1987 Aug; 65(8):717-25. PubMed ID: 3435667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of new immobilized-stabilized carboxypeptidase a derivative for production of aromatic free hydrolysates of proteins.
    Tardioli PW; Fernández-Lafuente R; Guisán JM; Giordano RL
    Biotechnol Prog; 2003; 19(2):565-74. PubMed ID: 12675602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.